Rituximab for intraocular lymphoma

Retina. 2009 Feb;29(2):129-32. doi: 10.1097/IAE.0b013e318192f574.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / therapeutic use*
  • Eye Neoplasms / drug therapy*
  • Humans
  • Lymphoma, B-Cell / drug therapy*
  • Optic Nerve Neoplasms / drug therapy*
  • Retinal Neoplasms / drug therapy*
  • Rituximab
  • Vitreous Body*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab